Elizabeth Radcliffe, Vice President of Finance and Strategy; Michael Gilman, Chief Executive Officer; Jennifer Petter, Founder and Chief Scientific Officer; Heather Lounsbury, Vice President of Business and Technical Operations; James Barsoum, Vice President of Research; Jacques Dumas, Senior Vice President of Drug Discovery (Arrakis Therapeutics)

Arrakis Therapeutics has been dodging pharma suitors since its early days, keeping its head down, building its RNA-targeting technology and “politely declining” advances “because we weren’t ready.”

Read Press Release